DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,122 filers reported holding DANAHER CORPORATION in Q2 2024. The put-call ratio across all filers is 1.04 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,749 | -0.6% | 7,000 | -0.7% | 0.32% | -2.1% |
| Q1 2024 | $1,760 | +7.1% | 7,047 | -0.8% | 0.33% | -2.1% |
| Q4 2023 | $1,644 | -6.7% | 7,105 | +0.1% | 0.34% | -15.9% |
| Q3 2023 | $1,762 | -8.8% | 7,099 | -11.7% | 0.40% | +12.3% |
| Q2 2023 | $1,931 | -3.7% | 8,041 | +1.0% | 0.36% | -10.3% |
| Q1 2023 | $2,006 | -7.1% | 7,960 | -2.2% | 0.40% | -11.1% |
| Q4 2022 | $2,160 | -99.9% | 8,136 | +1.1% | 0.45% | -2.4% |
| Q3 2022 | $2,079,000 | -2.6% | 8,051 | -4.4% | 0.46% | +8.5% |
| Q2 2022 | $2,134,000 | -35.4% | 8,420 | -25.2% | 0.42% | +4.7% |
| Q1 2022 | $3,301,000 | -30.6% | 11,254 | -22.2% | 0.40% | +8.9% |
| Q4 2021 | $4,758,000 | -20.2% | 14,465 | -26.1% | 0.37% | -16.2% |
| Q3 2021 | $5,960,000 | +11.6% | 19,578 | -1.6% | 0.44% | +16.5% |
| Q2 2021 | $5,341,000 | +4.0% | 19,897 | -12.8% | 0.38% | +7.9% |
| Q1 2021 | $5,135,000 | +4.7% | 22,813 | +3.3% | 0.35% | -6.9% |
| Q4 2020 | $4,906,000 | +11.7% | 22,081 | +8.3% | 0.38% | -10.4% |
| Q3 2020 | $4,391,000 | +22.4% | 20,392 | +0.5% | 0.42% | +24.8% |
| Q2 2020 | $3,587,000 | +45.3% | 20,284 | +13.7% | 0.34% | +6.6% |
| Q1 2020 | $2,468,000 | -8.4% | 17,835 | +6.4% | 0.32% | +11.6% |
| Q4 2019 | $2,695,000 | +4.2% | 16,755 | -10.7% | 0.28% | +6.7% |
| Q3 2019 | $2,587,000 | +4.4% | 18,767 | +6.4% | 0.27% | -0.7% |
| Q2 2019 | $2,478,000 | +4.2% | 17,641 | -2.0% | 0.27% | +2.3% |
| Q1 2019 | $2,377,000 | +27.5% | 18,006 | -0.5% | 0.26% | +66.5% |
| Q4 2018 | $1,865,000 | +4.0% | 18,088 | +0.2% | 0.16% | +9.7% |
| Q3 2018 | $1,794,000 | -7.4% | 18,047 | -8.1% | 0.14% | +2.9% |
| Q2 2018 | $1,938,000 | -11.5% | 19,629 | -12.3% | 0.14% | -4.8% |
| Q1 2018 | $2,191,000 | +4.3% | 22,377 | -1.1% | 0.15% | +7.3% |
| Q4 2017 | $2,100,000 | +4.1% | 22,623 | -3.8% | 0.14% | +2.2% |
| Q3 2017 | $2,017,000 | +1.0% | 23,521 | -0.4% | 0.13% | -2.2% |
| Q2 2017 | $1,997,000 | -7.8% | 23,623 | -6.5% | 0.14% | -8.1% |
| Q1 2017 | $2,165,000 | -99.9% | 25,267 | +12.6% | 0.15% | -21.6% |
| Q4 2016 | $1,746,000,000 | – | 22,432 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |